ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005


The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2022 and some content may be unavailable. To unlock all content for 2022, please visit the archives.

Abstract: TH-PO336

Using CRISPR-Cas9/Phosphoproteomics to Identify Kinase Substrates: Calcium/Calmodulin-Dependent Protein Kinase 2δ

Session Information

Category: Fluid‚ Electrolyte‚ and Acid-Base Disorders

  • 1001 Fluid‚ Electrolyte‚ and Acid-Base Disorders: Basic


  • Park, Euijung, National Heart Lung and Blood Institute, Bethesda, Maryland, United States
  • Yang, Chin-Rang, National Heart Lung and Blood Institute, Bethesda, Maryland, United States
  • Chen, Lihe, National Heart Lung and Blood Institute, Bethesda, Maryland, United States
  • Raghuram, Viswanathan, National Heart Lung and Blood Institute, Bethesda, Maryland, United States
  • Knepper, M. A., National Heart Lung and Blood Institute, Bethesda, Maryland, United States

Arginine vasopressin (AVP) plays a critical role in the regulation of water permeability in renal collecting duct (CD) cells via the V2 vasopressin receptor, which triggers a rise of intracellular cAMP and Ca2+. Ca2+ stimulates a wide range of cellular processes including actin cytoskeleton rearrangement, in part through Ca2+/CaM-dependent signaling. One potential target, strongly expressed in CD cells, is Ca2+/CaM-dependent protein kinase 2d (Camk2d). Here, we deleted Camk2d in mpkCCD cells and carried out phosphoproteomics to identify Camk2d target proteins.


Using two different gRNAs which target the Camk2d kinase domain, CRISPR/Cas9-mediated Camk2d knock-out cell lines were created. We carried out large-scale proteomic and phosphoproteomic analysis in the presence of dDAVP, (V2 selective AVP analog, 0.1 nM, 30 min) using TMT quantification versus wild-type cells to identify direct targets of Camk2d.


The quantitative phosphoproteomics revealed that, of the 11570 phosphopeptides quantified, 78 were significantly increased and 60 were decreased. Of the 60 downregulated sites, Tpd52 were previously identified as Camk2d targets in existing literature, but 59 of the identified sites are novel. Motif analysis of the decreased phosphorylation sites revealed a novel target preference of –(R/K)-X-X-p(S/T)-X-D- where R,K,S,T and D are standard single letter amino acid codes, X means “any amino acid” and p indicates the phosphorylated amino acid. Gene Ontology (GO) analysis identified that Cam2d-mediated protein phosphorylation is likely to be involved in regulation of actin polymerization as well as chromatin organization. In standard proteomics (n=5198), 23 proteins significantly increased and 24 were decreased. GO term analysis mapped the regulated proteins to chromatin organization and histone modification, consistent with the phosphoproteomic data.


We identified multiple novel Camk2d phosphorylation targets that have potential roles in vasopressin’s action to regulate water transport in the renal collecting duct, especially with regard to Ca2+/CaM-dependent regulation of the actin cytoskeleton and chromatin organization. The large increase in the number of recognized phosphorylation targets allowed identification of a new target sequence preference motif for Camk2d.